您的位置: 首页 > 2023年8月 第54卷 第8期 > 文字全文
2023年7月 第38卷 第7期11
目录

不同贫血类型患者铁蛋白水平、甲状腺功能检测结果对比分析

Comparative analysis of ferritin level and thyroid function in patients with different types of anemia

来源期刊: 广州医药 | 29-34 发布时间:2023-09-13 收稿时间:2025/11/13 18:31:40 阅读量:34
作者:
关键词:
不同贫血类型铁蛋白甲状腺功能
different types of anemiaferritinthyroid function
DOI:
10.3969/j.issn.1000-8535.2023.08.005
收稿时间:
2022-12-05 
修订日期:
 
接收日期:
 
引用总数:
1  
目的 探讨不同贫血类型患者铁蛋白水平、甲状腺功能检测结果对比分析。方法 前瞻性选取2018年11月—2021年11月我院收治的240例贫血患者作为研究对象。将患者分为小细胞低色素性贫血组(n=75),正细胞性贫血组(n=100)和大细胞性贫血组(n=65)。检查患者甲状腺功能[甲状腺素(TSH)、游离三碘甲腺原氨酸(FT3)、游离甲状腺素(FT4)]和铁蛋白(SF)表达水平。采用Spearman检验进行相关性分析;采用Logistics回归模型进行回归分析。结果 3组患者红细胞(RBC)、血红蛋白(Hb)、平均红细胞容积(MCV)、红细胞平均血红蛋白浓度(MCHC)、平均红细胞血红蛋白含量(MCH)、血清肌酐(Scr)间存在差异(P<0.05);大细胞性贫血组TSH、FT3和SF低于正细胞性贫血组和小细胞低色素性贫血组(P<0.05),而FT4高于正细胞性贫血组和小细胞低色素性贫血组(P<0.05);贫血类型与TSH、FT4、FT3和SF呈正相关(P<0.05);多因素Logistics回归分析结果显示,TSH、FT4、FT3和SF在3个模型中均为独立危险因素(P<0.05)。结论 不同贫血类型患者间甲状腺功能和铁蛋白表达水平存在显著差异,大细胞性贫血组TSH、FT3和SF低于正细胞性贫血组和小细胞低色素性贫血组,而FT4更高,甲状腺功能指标和铁蛋白均是各种类型贫血发生的危险因素。
Objective To explore the comparative analysis of ferritin level and thyroid function detection results in patients with different types of anemia.Methods A total of 240 anemia patients admitted to our hospital from November 2018 to November 2021 were prospectively selected as research objects.The patients were divided into microcytic hypochromic anemia group(n=75),normocytic anemia group(n=100),and macrocytic anemia group(n=65).The expression levels of thyroid function[thyroxine(TSH),free triiodothyronine(FT3),free thyroxine(FT4)]and ferritin(SF)were examined.Correlation analysis was performed by Sperman test.The logistic regression model was adopted for regression analysis.Results There were significant differences in red blood cell,hemoglobin,mean corpuscular volume,mean corpuscular hemoglobin concentration,mean corpuscular hemoglobin content and serum creatinine among three groups(P<0.05).TSH,FT3 and SF in macrocytic anemia group were significantly lower than those in normocytic anemia group and microcytic hypochromic anemia group(P<0.05),while FT4 was significantly higher than that in normocytic anemia group and microcytic hypochromic anemia group(P<0.05).The type of anemia was positively correlated with TSH,FT4,FT3 and SF(P<0.05).The results of multi-factor logistics regression analysis showed that TSH,FT4,FT3 and SF were independent risk factors in the three models(P<0.05).Conclusions There were significant differences in thyroid function and ferritin expression levels among patients with different types of anemia.Macrocytic anemia group TSH,FT3 and SF were lower than those in normocytic anemia group and microcytic hypochromic anemia group,while FT4 was higher.Both thyroid function indexes and ferritin were risk factors for various types of anemia.
1、 MALAKI M.Anemia and ferritin in hemodialysis:A new insight for evaluation of managing system[J].Saudi J Kidney Dis Transpl,2018,29(3):735-736. MALAKI M.Anemia and ferritin in hemodialysis:A new insight for evaluation of managing system[J].Saudi J Kidney Dis Transpl,2018,29(3):735-736.
2、 SZCZEPANEK-PARULSKA E,HERNIK A,RUCHA?A M.Anemia in thyroid diseases[J].Pol Arch Intern Med,2017,127(5):352-360. SZCZEPANEK-PARULSKA E,HERNIK A,RUCHA?A M.Anemia in thyroid diseases[J].Pol Arch Intern Med,2017,127(5):352-360.
3、 SOLIMAN A T,de SANCTIS V,YASSIN M,et al.Chronic anemia and thyroid function[J].Acta Biomed,2017,88(1):119-127. SOLIMAN A T,de SANCTIS V,YASSIN M,et al.Chronic anemia and thyroid function[J].Acta Biomed,2017,88(1):119-127.
4、 左新河,牧亚峰,赵勇.健脾生血片治疗甲状腺功能亢进症合并贫血临床观察[J].世界中医药,2017,12(3):580-581,586. 左新河,牧亚峰,赵勇.健脾生血片治疗甲状腺功能亢进症合并贫血临床观察[J].世界中医药,2017,12(3):580-581,586.
5、 倪爱青,何大强,杨金军.妊娠期糖尿病患者孕期甲状腺功能和贫血指标的变化及与母婴结局的相关性[J].中国妇幼保健,2022,37(2):193-196. 倪爱青,何大强,杨金军.妊娠期糖尿病患者孕期甲状腺功能和贫血指标的变化及与母婴结局的相关性[J].中国妇幼保健,2022,37(2):193-196.
6、 刘婷,李洋,孙娇琳,等.血清可溶性转铁蛋白受体水平与慢性阻塞性肺疾病患者认知障碍程度的相关性研究[J].实用心脑肺血管病杂志,2020,28(3):66-70. 刘婷,李洋,孙娇琳,等.血清可溶性转铁蛋白受体水平与慢性阻塞性肺疾病患者认知障碍程度的相关性研究[J].实用心脑肺血管病杂志,2020,28(3):66-70.
7、 李晓晴,惠海英,苏亚妮.白癜风进展期患者甲状腺功能状况与CD4+CD25+ T细胞水平关系的研究[J].陕西医学杂志,2017,46(5):667-668. 李晓晴,惠海英,苏亚妮.白癜风进展期患者甲状腺功能状况与CD4+CD25+ T细胞水平关系的研究[J].陕西医学杂志,2017,46(5):667-668.
8、 赵瑾,周艳红,白小英.子宫肌瘤患者凝血功能与子宫体积关系及其对继发性贫血的预测价值研究[J].陕西医学杂志,2022,51(2):164-167. 赵瑾,周艳红,白小英.子宫肌瘤患者凝血功能与子宫体积关系及其对继发性贫血的预测价值研究[J].陕西医学杂志,2022,51(2):164-167.
9、 JIMENEZ K M,GASCHE C.Management of iron deficiency anaemia in inflammatory bowel disease[J].Acta Haematol,2019,142(1):30-36. JIMENEZ K M,GASCHE C.Management of iron deficiency anaemia in inflammatory bowel disease[J].Acta Haematol,2019,142(1):30-36.
10、 WINTHER K H,RAYMAN M P,BONNEMA S J,et al.Selenium in thyroid disorders - essential knowledge for clinicians[J].Nat Rev Endocrinol,2020,16(3):165-176. WINTHER K H,RAYMAN M P,BONNEMA S J,et al.Selenium in thyroid disorders - essential knowledge for clinicians[J].Nat Rev Endocrinol,2020,16(3):165-176.
11、 STAUDER R,VALENT P,THEURL I.Anemia at older age:etiologies,clinical implications,and management[J].Blood,2018,131(5):505-514. STAUDER R,VALENT P,THEURL I.Anemia at older age:etiologies,clinical implications,and management[J].Blood,2018,131(5):505-514.
12、 PASRICHA SR,COLMAN K,CENTENO-TABLANTE E,et al.Revisiting WHO haemoglobin thresholds to define anaemia in clinical medicine and public health[J].Lancet Haematol,2018,5(2):e60-e62. PASRICHA SR,COLMAN K,CENTENO-TABLANTE E,et al.Revisiting WHO haemoglobin thresholds to define anaemia in clinical medicine and public health[J].Lancet Haematol,2018,5(2):e60-e62.
13、 GAFTER-GVILI A,SCHECHTER A,ROZEN-ZVI B.Iron deficiency anemia in chronic kidney disease[J].Acta Haematol,2019,142(1):44-50. GAFTER-GVILI A,SCHECHTER A,ROZEN-ZVI B.Iron deficiency anemia in chronic kidney disease[J].Acta Haematol,2019,142(1):44-50.
14、 NIE G Y,WANG R,LIU P,et al.Mild anemia may affect thyroid function in pregnant Chinese women during the first trimester[J].Front Endocrinol(Lausanne),2021,9(12):772917. NIE G Y,WANG R,LIU P,et al.Mild anemia may affect thyroid function in pregnant Chinese women during the first trimester[J].Front Endocrinol(Lausanne),2021,9(12):772917.
15、 CHAPARRO C M,SUCHDEV P S.Anemia epidemiology,pathophysiology,and etiology in low- and middle-income countries[J].Ann N Y Acad Sci,2019,1450(1):15-31. CHAPARRO C M,SUCHDEV P S.Anemia epidemiology,pathophysiology,and etiology in low- and middle-income countries[J].Ann N Y Acad Sci,2019,1450(1):15-31.
16、 CASCIO M J,DELOUGHERY T G.Anemia:Evaluation and diagnostic tests[J].Med Clin North Am,2017,101(2):263-284. CASCIO M J,DELOUGHERY T G.Anemia:Evaluation and diagnostic tests[J].Med Clin North Am,2017,101(2):263-284.
1、王艳飞.特发性膜性肾病合并甲状腺功能减退危险因素分析及中医证型特点研究[D].天津中医药大学,2024.DOI:10.27368/d.cnki.gtzyy.2024.000630. 王艳飞.特发性膜性肾病合并甲状腺功能减退危险因素分析及中医证型特点研究[D].天津中医药大学,2024.DOI:10.27368/d.cnki.gtzyy.2024.000630.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录